发现可见异物！ 2批次辅酶Q10抽检不合格

Core Viewpoint - The announcement highlights that two batches of Coenzyme Q10 injection produced by Liaoning Zhonghai Kang Pharmaceutical Co., Ltd. were found to be non-compliant due to issues with appearance and visible foreign matter [1] Company Overview - Liaoning Zhonghai Kang Pharmaceutical Co., Ltd. was established in June 2008 and is located in Benxi City, Liaoning Province, with a registered capital of over 38.12 million yuan [1] - The company focuses on the research and development of cardiovascular drugs and anti-tumor medications, primarily developing injectable products that cover various therapeutic areas including cardiovascular, endocrine, digestive, renal, rheumatology, and liver diseases [1] - The company was listed on the New Third Board in November 2016 [1] Regulatory Actions - The Liaoning Provincial Drug Supervision Administration has taken necessary control measures and initiated investigations against the non-compliant products, and has notified relevant provincial drug regulatory departments regarding non-compliant products produced by enterprises from other provinces [1] Product Quality Issues - The non-compliance issues pertain to the characteristics of the product, which include appearance, odor, taste, solubility, and physical constants, reflecting the quality attributes of the drug [1] - Visible foreign matter refers to insoluble substances that can be observed under specified visual conditions, typically with a particle size or length greater than 50 micrometers [1]